Guru Ownership Trend
Guru Analysis for Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.4 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $539,489.63 net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 19.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Aura Biosciences, Inc. (AURA)
Major holders include Renaissance Technologies (RenTech) ($791,340), Steven Cohen ($298,071), Cliff Asness ($75,548). According to the latest reported data, 3 tracked investment managers collectively hold approximately 213,754 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $539,489.63, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited AURA. The total reported sell value was $17,957.77.
Yes, 1 managers opened new positions in AURA, and 1 increased their existing holdings. The total reported buy value was $557,447.4.